Cardinal Health Specialty Solutions to Provide Regulatory Support for NCATS Rare Disease Program

DUBLIN, Ohio – June 30, 2015 – Cardinal Health Specialty Solutions has been selected to provide regulatory support to the National Center for Advancing Translational Sciences (NCATS) for its Therapeutics for Rare and Neglected Diseases (TRND) program under a research subcontract with Leidos Biomedical Research, Inc. (Leidos Biomed). NCATS is part of the National Institutes of Health (NIH).

NCATS’ TRND program is designed to advance pre-clinical development of small molecule and biologic therapies, as well as compilation and submission of investigational new drug applications (INDs) to the U.S. Food and Drug Administration for these therapies.

Read more

ABOUT US: Cardinal Health Specialty Solutions Provides Regulatory Support to Help National Institutes of Health Develop Therapeutics for Rare and Neglected Diseases.